QJP: Catheter, Percutaneous, Neurovasculature

Product code QJP, “Catheter, Percutaneous, Neurovasculature” in FDA's classification database, is a Class II device type under 21 CFR 870.1250 (percutaneous catheter), reviewed by FDA's Cardiovascular panel. FDA's 510(k) database lists 103 clearances under QJP, 103 of them since 2011.
Updated Oct 29, 2026 · Clearances from FDA’s 510(k) database, as of Oct 29, 2026
Product code
QJP
Regulation
21 CFR 870.1250
Class
II
Panel
Cardiovascular
Clearances
103
Most recent
Oct 9, 2026
Median review, last 2 years
143 days
Third-party review
Not eligible
Implant
No

What it covers

To provide vascular access to the neurovasculature for interventional or diagnostic procedures

FDA’s definition of product code QJP, from the Product Classification database.

Recent clearances

510(k)DeviceApplicantDecisionType
K261649Excelsior Reach MicrocatheterStryker NeurovascularOct 9, 2026Traditional
K261938APRO 88 CatheterAlembic, LLCOct 6, 2026Traditional
K253422OAB Delivery CatheterCognition Medical Corp.Oct 2, 2026Traditional
K260220Route 92 Medical Full Length 046 Access SystemRoute 92 Medical, Inc.Sep 16, 2026Traditional
K26227770 NeuGlide CatheterPiraeus Medical, Inc.Sep 4, 2026Special
K261176Zoom 4S CatheterImperative Care, Inc.Aug 28, 2026Traditional
K254071p17 XR MicrocatheterWallaby MedicalAug 18, 2026Traditional
K260199SLIM MicrocatheterBalt USA, LLCJul 13, 2026Traditional
K253901Millipede88 Access CatheterPerfuze, Ltd.Jul 9, 2026Traditional
K261889Trevo Trak 21 MicrocatheterStryker NeurovascularJul 1, 2026Special
From FDA’s 510(k) database, as of Oct 29, 2026Export CSV (100 rows free · all 103 with a free account)

Clearances by year

103 QJP 510(k)s were cleared from 2011 to Oct 29, 2026. Days to decision run from the day FDA received the 510(k) to its decision, including time on hold.

YearClearancesMedian days to decision
2026 (so far)22141
202514116
202418188
202314184
202214206
202112139
2020972

Who submits

45 applicants cleared a QJP device since 2011. 78% of the clearances went to applicants in United States, then Ireland (7%), Japan (7%) and China (6%). By type: Traditional 69% and Special 31%. 4 went through a third-party review organization.

ApplicantClearances since 2011
Stryker Neurovascular10
Route 92 Medical, Inc.7
Asahi Intecc Co., Ltd.6
Balt USA, LLC6
Imperative Care, Inc.6
Penumbra, Inc.5
Perfuze, Ltd.5
Cerenovus, Inc.4

How FDA classifies it

Class II (performance standards).

From 21 CFR 870.1250.

Standards

21 CFR 870.1250 names no consensus standards. Check FDA’s recognized standards database, or ask which standards recent QJP clearances declared.

Ask about QJP

US FDA devices: 510(k), De Novo, guidance, 21 CFR

Questions about QJP

What is FDA product code QJP?

Product code QJP, “Catheter, Percutaneous, Neurovasculature” in FDA's classification database, is a Class II device type under 21 CFR 870.1250 (percutaneous catheter), reviewed by FDA's Cardiovascular panel. FDA's 510(k) database lists 103 clearances under QJP, 103 of them since 2011.

How many 510(k) clearances are there under QJP?

FDA’s 510(k) database listed 103 clearances under QJP as of Oct 29, 2026, 103 of them decided since 2011; the most recent decision was Oct 9, 2026. The Predicate Finder searches the live database.

How long does FDA take to clear a QJP 510(k)?

For the 43 QJP clearances decided in the two years before Oct 29, 2026, the median time from FDA receiving the 510(k) to its decision was 143 days. That counts calendar days, including time the submission was on hold waiting for answers from the submitter.

Which companies have the most QJP clearances?

Since 2011: Stryker Neurovascular (10), Route 92 Medical, Inc. (7), Asahi Intecc Co., Ltd. (6), Balt USA, LLC (6) and Imperative Care, Inc. (6). 45 applicants have cleared a QJP device in that time.

Sources

  1. FDA product classification: QJP · Product Classification database
  2. 21 CFR 870.1250: Percutaneous catheter · eCFR, as of Oct 27, 2026
  3. openFDA 510(k) query for QJP · run Oct 29, 2026
  4. 510(k) Premarket Notification database · FDA, accessdata.fda.gov
Follow QJPGet an email when FDA clears, recalls or publishes guidance for QJP devices.

Know what FDA already cleared.